Gibraltar, a British territory located in southern Spain, has legalized the use of “non-smoking” cannabis for medical purposes for various identified diseases.
Medical officers working at the Gibraltar Health Authority (GHA) will be able to prescribe cannabis products to patients. SO,each practitioner will first have to undergo appropriate training on the use of these products, followed by ongoing training. Also,only the pharmacy of Saint-Bernard Hospital, managed by the GHA, will be able to distribute cannabis-based treatments.
Patients eligible for medical cannabis must diagnosed with one of the following diseases:
- moderate to severe muscle spasticity in multiple sclerosis that has not responded to traditional treatments.
- severe and refractory epilepsy that has not responded to traditional treatments.
- severe pain not relieved by pain medication.
- intractable nausea and vomiting associated with chemotherapy.
- Each prescribed product must be specifically approved by the GHA as safe and effective before its distribution is authorized.
Dr. Krishna Rawal, the hospital’s medical director, described the reforms as a “decisive step” for health in Gibraltar, based on “extensive research and consultation”.
“I am extremely keen to offer patients as many options as possible for their medical treatment and recovery. In my opinion, cannabis oil certainly has a place in modern medical care provided to some patients. In Addition, i am convinced that the increased use of cannabis for medical purposes will generate overwhelming evidence in favor of its use. »
The United Kingdom legalized medical cannabis in 2018, with effective access one year later very limited.